Study #2022-0472
Use of Immune Checkpoint Inhibitors in Cancer Patients and their Effects on T-cell and Monocyte Exhaustion and Clinical Outcomes During Septic Shock
MD Anderson Study Status
Enrolling
Treatment Agent
Description
ICIs, septic shock and immunosuppression
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Physician name:
Cristina Gutierrez
Department:
Critical Care
For general questions about clinical trials:
1-855-981-0775
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.